Screener
Prestige Consumer Healthcare PBH Accrued production costs
Accrued production costs at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept pbh:AccruedProductionCostsCurrent.
The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:15 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001295947-26-000042
| (In thousands) | June 30, 2026 | March 31, 2026 |
|---|---|---|
| Accrued compensation costs | 7,598 | 12,127 |
| Accrued broker commissions | 1,479 | 1,476 |
| Income taxes payable | 7,569 | 733 |
| Accrued professional fees | 8,111 | 8,290 |
| Accrued production costs | 4,755 | 6,018 |
| Line of credit | 3,639 | 2,986 |
| Other accrued liabilities | 7,867 | 9,728 |
| $78,783 | $72,989 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Prestige Consumer Healthcare's accrued production costs?
- Prestige Consumer Healthcare (PBH) reported accrued production costs of $4.76M in Q2 2026.
- How has Prestige Consumer Healthcare's accrued production costs changed year-over-year?
- Prestige Consumer Healthcare's accrued production costs decreased by 5.4% year-over-year, from $5.03M to $4.76M.
- What is the long-term trend for Prestige Consumer Healthcare's accrued production costs?
- Over 5 years (2021 to 2026), Prestige Consumer Healthcare's accrued production costs has grown at a 15.9% compound annual growth rate (CAGR), from $2.88M to $6.02M.
- What does accrued production costs mean?
- Accrued production costs as reported by Prestige Consumer Healthcare Inc..
Ask your AI about Prestige Consumer Healthcare's accrued production costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude